Prehospital therapy with the platelet glycoprotein IIb/IIIa inhibitor eptifibatide in patients with suspected acute coronary syndromes: The bochum feasibility study

Chest

Volumn 126, Issue 3, 2004, Pages 935-941

  Hanefeld, Christoph ^a   Sirtl, Clemens ^b   Spiecker, Martin ^a   Bojara, Waldemar ^a   Grewe, Peter H ^a   Lawo, Thomas ^a   Mügge, Andreas ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

Acute coronary syndrome; Eptifibatide; Glycoprotein IIb IIIa inhibitor; Myocardial infarction; Primary percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FUROSEMIDE; HEPARIN; NITRATE; TIROFIBAN;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DEATH; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION; THORAX PAIN; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 4544260868     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.3.935     Document Type: Article

References (12)

1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations; a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000; 102:1193-1209
2. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003; 24:28-66
3. Cannon CP, Sayah AJ, Walls RM. Prehospital thrombolysis: an idea whose time has come. Clin Cardiol 1999; 22(suppl):10-19
4. Stern R, Arntz HR. Prehospital thrombolysis in acute myocardial infarction. Eur J Emerg Med 1998; 5:471-479
5. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344:1895-1903
6. Roffi M, Chew DP, Mukherjee D, et al. Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Eur Heart J 2002; 23:1441-1448
7. Batchelor WB, Tolleson TR, Huang Y, et al. Randomized comparison of platelet inhibition with abciximab, tirofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Circulation 2002; 106:1470-1476
8. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349:733-742
9. Kudenchuk PJ, Maynard C, Cobb LA, et al. Utility of the prehospital electrocardiogram in diagnosing a coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) project. J Am Coll Cardiol 1998; 32:17-27
10. European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993; 329:383-389
11. Mahaffey KW, Harrington RA, Simoons ML, et al. Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina; receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 1999; 99:2371-2377
12. Cutlip DE, Cove CL, Irons D, et al. Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcome. Am J Cardiol 2001; 88:62-64